 |
|
Bladder cancer detected via amplified gene in cells found in urine
September 24, 2008HOUSTON - Counting the copies of a specific gene in cells gathered from a urine sample may provide a simple, noninvasive way to detect bladder cancer, a team led by researchers at The University of Texas M. D. Anderson Cancer Center reports in the Journal of the National Cancer Institute.
When the telltale gene, Aurora kinase A, is numerous and overexpressed in urothelial cells, errors during cell division follow, the team also found. The new cells have too few or too many chromosomes, instead of the normal pairs of 23 chromosomes.
"Abnormal chromosome counts are the most fundamental feature - the signature - of human cancers," said senior author Bogdan Czerniak, M.D., Ph.D., professor in M. D. Anderson's Department of Pathology. "We have further clarified the role that the Aurora kinase A gene (AURKA) plays in this misaggregation of chromosomes in bladder cancer.
"As a biomarker, Aurora kinase A can detect bladder cancer in voided urine with high degrees of sensitivity and specificity," Czerniak said.
Bladder cancer is the fifth most common cancer in the United States, with an estimated 68,000 new cases and about 14,000 deaths annually. It is usually diagnosed after a patient has symptoms by biopsy of tissue removed during a cytoscopic examination of the bladder or microscopic analysis of cells found in the urine.
FISH finds gene, ferrets out bladder cancer
The team used fluorescence in situ hybridization (FISH) to count copies of the gene in urothelial cells from the bladder culled from urine samples. A blinded analysis of samples from 23 bladder cancer patients and seven cancer-free controls showed the AURKA biomarker identified all 23 cancer cases and correctly characterized six of the seven controls as not having bladder cancer.
The biomarker test was validated in urine samples from a separate group of 100 bladder cancer patients and 148 controls. Blinded analysis showed the biomarker accurately identified 87 of the cancer cases and characterized 96.6 percent of the controls as cancer-free, producing only five false positives.
Cytological analysis was conducted on additional samples from 59 of the cancer cases. Microscopic examination of the cells identified 48 of the 59 cancers (81.4 percent). Nine of the 11 cases mischaracterized by cytology were correctly identified by the FISH Aurora kinase A test. "It appears that the biomarker is better than cytological analysis of cells isolated from urine," Czerniak said.
"Our next step is to develop a U.S. Food and Drug Administration approved, commercially available test," Czerniak said. That will require independent validation in prospective, multi-institutional clinical trials. If approved, the test could detect new and recurrent cases earlier, leading to increased bladder preservation and improved survival.
Greater Aurora kinase A, more chromosomal confusion
In a series of experiments that led to the urine tests, the scientists demonstrated that Aurora kinase A overexpression is tightly associated with chromosomal misaggregation, and both occur most heavily in the most aggressive forms of bladder cancer.
The gene encodes a protein important to orderly cell division and equal segregation of chromosomes. Aurora kinase A is a critical protein involved in the duplication, maturation and distribution of centrosomes, which function during cell division to assure the two daughter cells receive the normal 23 pairs of chromosomes.
Current study co-author Subrata Sen, Ph.D., associate professor in M. D. Anderson's Department of Molecular Pathology, and colleagues showed in 1998 that AURKA is an oncogene that is overexpressed and amplified in many types of human cancers, contributing to creation of abnormal centrosomes. These, in turn, lead to abnormal numbers of chromosomes in the daughter cells - a condition called aneuploidy.
Sen, Czerniak and others, showed that the AURKA gene is overexpressed and numerous in human bladder cancer and in 2004 reported that it destabilizes and inhibits the cancer-fighting gene p53.
Building on this work, the team analyzed 15 paired samples of bladder cancer and nearby urothelium for AURKA overexpression. Higher levels of expression were associated with high-grade, late-stage tumors with abnormal numbers of chromosomes. Next, they analyzed 11 bladder cancer lines and found a tight correlation between high levels of AURKA expression and multiple copies of chromosomes.
Finally, they forced AURKA overexpression in a urothelial cell line and found that greater gene activity was associated with a four-fold increase in the number of cells with more than three centrosomes, a two-fold increase in cells with multiple copies of chromosomes 3, 7 and 17, and a four-fold increase in the percentage of cells with abnormal chromosomal counts.
University of Texas M. D. Anderson Cancer Center
"As a biomarker, Aurora kinase A can detect bladder cancer in voided urine with high degrees of sensitivity and specificity," Czerniak said.
Bladder cancer is the fifth most common cancer in the United States, with an estimated 68,000 new cases and about 14,000 deaths annually. It is usually diagnosed after a patient has symptoms by biopsy of tissue removed during a cytoscopic examination of the bladder or microscopic analysis of cells found in the urine.
FISH finds gene, ferrets out bladder cancer
The team used fluorescence in situ hybridization (FISH) to count copies of the gene in urothelial cells from the bladder culled from urine samples. A blinded analysis of samples from 23 bladder cancer patients and seven cancer-free controls showed the AURKA biomarker identified all 23 cancer cases and correctly characterized six of the seven controls as not having bladder cancer.
The biomarker test was validated in urine samples from a separate group of 100 bladder cancer patients and 148 controls. Blinded analysis showed the biomarker accurately identified 87 of the cancer cases and characterized 96.6 percent of the controls as cancer-free, producing only five false positives.
Cytological analysis was conducted on additional samples from 59 of the cancer cases. Microscopic examination of the cells identified 48 of the 59 cancers (81.4 percent). Nine of the 11 cases mischaracterized by cytology were correctly identified by the FISH Aurora kinase A test. "It appears that the biomarker is better than cytological analysis of cells isolated from urine," Czerniak said.
"Our next step is to develop a U.S. Food and Drug Administration approved, commercially available test," Czerniak said. That will require independent validation in prospective, multi-institutional clinical trials. If approved, the test could detect new and recurrent cases earlier, leading to increased bladder preservation and improved survival.
Greater Aurora kinase A, more chromosomal confusion
In a series of experiments that led to the urine tests, the scientists demonstrated that Aurora kinase A overexpression is tightly associated with chromosomal misaggregation, and both occur most heavily in the most aggressive forms of bladder cancer.
The gene encodes a protein important to orderly cell division and equal segregation of chromosomes. Aurora kinase A is a critical protein involved in the duplication, maturation and distribution of centrosomes, which function during cell division to assure the two daughter cells receive the normal 23 pairs of chromosomes.
Current study co-author Subrata Sen, Ph.D., associate professor in M. D. Anderson's Department of Molecular Pathology, and colleagues showed in 1998 that AURKA is an oncogene that is overexpressed and amplified in many types of human cancers, contributing to creation of abnormal centrosomes. These, in turn, lead to abnormal numbers of chromosomes in the daughter cells - a condition called aneuploidy.
Sen, Czerniak and others, showed that the AURKA gene is overexpressed and numerous in human bladder cancer and in 2004 reported that it destabilizes and inhibits the cancer-fighting gene p53.
Building on this work, the team analyzed 15 paired samples of bladder cancer and nearby urothelium for AURKA overexpression. Higher levels of expression were associated with high-grade, late-stage tumors with abnormal numbers of chromosomes. Next, they analyzed 11 bladder cancer lines and found a tight correlation between high levels of AURKA expression and multiple copies of chromosomes.
Finally, they forced AURKA overexpression in a urothelial cell line and found that greater gene activity was associated with a four-fold increase in the number of cells with more than three centrosomes, a two-fold increase in cells with multiple copies of chromosomes 3, 7 and 17, and a four-fold increase in the percentage of cells with abnormal chromosomal counts.
University of Texas M. D. Anderson Cancer Center
Bladder Cancer Current Events and Bladder Cancer News RSSPrediction model superior to traditional criteria in bladder treatment decision
A statistical model can accurately predict which patients will have poor outcomes after bladder surgery and can determine the need for chemotherapy.
Hopkins scientists find cells responsible for bladder cancer's spread
Johns Hopkins scientists have tracked down a powerful set of cells in bladder tumors that seem to be primarily responsible for the cancer's growth and spread using a technique that takes advantage of similarities between tumor and organ growth.
Variation in prostate stem cell antigen gene raises bladder cancer risk
Researchers have pinpointed a specific gene variation that causes increased risk of urinary bladder cancer, according to a scientific team led by The University of Texas M. D. Anderson Cancer Center.
UT Southwestern researchers investigate high-risk populations for bladder-cancer screenings
A new study by UT Southwestern Medical Center researchers sheds light on the challenges involved in identifying which high-risk population would benefit most from bladder-cancer screening.
DKK-3 and WIF-1: Proteins related to liver cancer development?
Liver cancer is one of the most fatal human malignancies and the third most frequent cause of tumor-related death, about half a million people globally each year.
Certain ecologic factors associated with greater risk of bladder cancer
Persons drinking well water (as opposed to public supply) may be at an increased risk of bladder cancer, according to new research from the University of Alabama at Birmingham. Researchers will present data about the relationship between bladder cancer and certain ecologic factors including water source and UV radiation levels at the 104th Annual Scientific Meeting of the American Urological Association (AUA).
Mayo Clinic researcher says improved detection of bladder tumors reduces cancer recurrence
Making tumors inside the bladder fluoresce red under blue light allows physicians to more easily find and remove them, substantially reducing the rate at which these cancers come back, says a Mayo Clinic physician who is presenting results of a large, multicenter international clinical trial.
Genetic Variants Predict Recurrence of Bladder Cancer, Patient Survival
Scientists at The University of Texas M. D. Anderson Cancer Center have discovered genetic variations in the inflammation pathway that reduce the likelihood of recurrence and increase survival of patients with non-muscle invasive bladder cancer (NMIBC) who are treated with mainstream therapy.
More intense bladder cancer treatment does not improve survival, U-M study finds
Despite enduring more invasive tests and medical procedures, patients who were treated aggressively for early stage bladder cancer had no better survival than patients who were treated less aggressively.
New Discovery Raises Doubts About Use of Certain Targeted Therapies in Bladder Cancer
Researchers at the University of Virginia Health System have found that one of the genes commonly thought to promote the growth and spread of some types of cancers is in fact beneficial in bladder cancer - a major discovery that could significantly alter the way bladder cancers are treated in the future.
More Bladder Cancer Current Events and Bladder Cancer News Articles
 |
Bladder Cancer: A Resource Guide for Patients and Their Families by Gary Dunetz (Author) If you, a loved one or friend has been diagnosed with bladder cancer, learning the basics is of utmost importance. It is essential to understand the nature of the disease, the work up and variety of treatments which are available. This book is comprehensive yet user friendly. It is written in a question and answer format in conversational tone. The physician author is a clinical urologist who has guided many individuals with bladder cancer through diagnosis and the various forms of treatment. This resource should enable those with bladder cancer and their family and friends to face this challenge with reason. After reading this book, you will be able to make an informed decision as you collaborate with your physician to regain your health. This book is written to allow the reader to have... |
 |
100 Questions & Answers About Bladder Cancer by Pamela Ellsworth (Author), Brett Carswell (Author) Approximately 62,000 people are diagnosed with bladder cancer each year, making bladder cancer the fourth most common type of cancer in men and the eighth most common type in women. Whether you're a newly diagnosed bladder cancer patient, a survivor, or a friend or relative of either, this book offers help. The only book to provide both the doctor's and patient's views, 100 Questions & Answers About Bladder Cancer gives you authoritative, practical answers to your questions about treatment options, post-treatment quality of life, coping strategies, sources of support, and much more. Written by two prominent urologists, with "insider" advice from actual patients, this book is an invaluable resource for anyone coping with the physical and emotional turmoil of this frightening disease. |
 |
Bladder Cancer (Cleveland Clinic Guide) by M D Raghavan (Author), Kathleen Tuthill (Author) Cancer that arises in the bladder is one of the most common malignancies in industrialized societies and yet is not well understood in the community at large. Bladder Cancer: A Cleveland Clinic Guide provides simple, non-medical explanations of this disease for people who have to deal with this illness, either as patients or as those who care for these patients. |
 |
The Guide to Living with Bladder Cancer by Dr. Mark P. Schoenberg MD FACS (Author) Johns Hopkins Univ., Baltimore, MD. Text for families and patients facing this disease. Discusses the structure and function of the urinary tract, an overview of bladder cancer and risk factors, symptoms, surgery, life after surgery, principles of chemotherapy, tests and diagnosis, and major surgical procedures. Hardcover, soft not available |
 |
Bladder Cancer Awareness Ribbon Mouse Pad by MyHeritageWear.com The Bladder Cancer Ribbon proudly displayed on a mouse pad. There is no better way to achieve awareness for the meaning of the Bladder Cancer Ribbon than to display it on your mouse pad for everyone to see. The mouse pad measures at 9.25 x 7.75, it is machine washable, and the colors will not fade or run. Start gaining awareness today by presenting your Bladder Cancer Ribbon mouse pad at work or at home. It is certain to keep your mouse rolling in style all while gaining support and awareness! |
 |
Fight Against Bladder Cancer T-shirt Large White by Shop Zeus |
 |
Krames Communications Brochure Bladder Cancer Understandng Ea - Model 1783 - Case Of 20 by Krames Communications Krames Communications Brochure Bladder Cancer Understandng Ea - Model 1783 - Case of 20 : This product is a non stock item that must be ordered from the manufacturer. As such, will appear on a separate order and follow at a later date. This item is NON-RETURNABLE. |
 |
Fight Against Bladder Cancer Mug by Design a Product LLC Text on mug: Fight Against Bladder Cancer * Custom coffee mugs are dishwasher-safe and microwave-safe. Colors are permanently baked into the mug''s surface. * If you have new ideas or need help selecting text for your custom coffee mugs please contact us. * Size: 11 oz. capacity ceramic coffee mug. |
 |
Treatment and Management of Bladder Cancer (with CD) by Seth P. Lerner (Editor), Mark Schoenberg (Editor), Cora Sternberg (Editor) Bladder cancer is an international public health problem affecting millions of people in both developed and underdeveloped nations. This major urologic malignancy was one of the first cancers to be linked to occupational and environmental exposure to carcinogens. Bladder cancer is the 5th most common cancer of American men and the 8th most common cancer of American women. Sixty thousand new cases of the disease are diagnosed each year in the US alone; disease prevalence is high in western nations due to the predominance of the chronic relapsing form of cancer that occurs in these countries (USA prevalence estimated to be 600,000; NCI-SEER database). This single fact makes bladder cancer one of the most expensive cancers to treat. Treatment and Management of Bladder Cancer, drawing on... |
 |
Olympian Labs Prosplex For Men by Olympian Labs The prostate is a doughnut shaped gland located behind the pubic bone and below the bladder in males. It surrounds the neck of the bladder and the urethra, a small tubular structure that drains urine from the bladder to the penis. The prostate gland is a common site of Malfunction of mind or bodys in the male genitourinary system. As men age, their prostate gland often enlarges. This condition is referred to as Benign Prostate Hypertrophy or BPH. Over 50% of American men will develop an enlarged prostate in their lifetime. Dietary supplementation of nutrients essential for prostate health have been shown to be effective in the relief of BPH. |
| © 2009 BrightSurf.com |